Source Genomics introduces Oxford Nanopore Whole Plasmid Sequencing Service
Olink® Proteomics Now Available
Source BioScience Expands Genomic Footprint
Pathology Reimagined: New digital pathology model
Source BioScience completes £18.5m strategic acquisition of LDPath Ltd to reimagine the future of pathology by combining cellular and digital pathology platforms
Integrated storage and delivery solutions from Source BioScience provide a reliable solution for distribution of the COVID 19 vaccine
Oxford Nanopore and SourceBio announce commercial partnership for UK COVID-19 testing service
Source Bioscience UK Ltd offer NHS COVID-19 testing
